Abstract B023: Personalized phenotypic ex vivo drug sensitivity platform identifies frequent HDAC inhibitor-based combination sensitivities in T-cell lymphomas

Authors: Jasmine Ya Hwee Goh, Sanjay De Mel, Masturah Rashid, Anand Jeyasekharan, Edward Kai-Hua Chow

Published: 2022-12-02

DOI: 10.1158/1538-7445.cancepi22-b023

Source: Full article


Abstract

Abstract